IUSTI Europe position statement on use of DoxyPEP: June 2024
This position statement is aimed at front-line clinical practitioners and public health authorities in WHO European Region providing services for people wishing to reduce their risk of acquiring sexually transmitted infections (STIs), including HIV.
Authors
- Andrew Winter (ORCID: https://orcid.org/0000-0002-8293-9462)
- Marco Cusini (ORCID: https://orcid.org/0000-0003-4757-6798)
- Michael Marks (ORCID: https://orcid.org/0000-0002-7585-4743)
- Otilia Mårdh (ORCID: https://orcid.org/0000-0002-0581-9838)
- Jørgen Skov Jensen (ORCID: https://orcid.org/0000-0002-7464-7435)
- Jackie Sherrard (ORCID: https://orcid.org/0000-0002-1310-0372)
- Magnus Unemo (ORCID: https://orcid.org/0000-0003-1710-2081)
- Deniz Gökengin (ORCID: https://orcid.org/0000-0003-0704-2302)
Institutions
- Statens Serum Institut (DK)
- Örebro University (SE)
- NHS Greater Glasgow and Clyde (GB)
- Buckinghamshire Healthcare NHS Trust (GB)
- Ege University (TR)
- Ospedale Maggiore (IT)
- London School of Hygiene & Tropical Medicine (GB)
- Hospital for Tropical Diseases (GB)
- University College London (GB)
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- International Journal of STD & AIDS
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1177/09564624241273801
- Citations
- 20
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 7.78